UK Regulators Review Eisai's Insomnia Treatment Application
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has accepted Eisai's application for lemborexant, an insomnia drug. This acceptance initiates the regulatory evaluation process, moving the treatment closer to potential availability in the United Kingdom.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.